Literature DB >> 11742249

Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma.

T Mori1, X Wang, A E Kline, C J Siao, C E Dixon, S E Tsirka, E H Lo.   

Abstract

Tissue plasminogen activator (tPA) may play a deleterious role after brain injury. Here, we compared the response to traumatic brain injury in tPA knockout (KO) and wildtype (WT) mice after controlled cortical impact. At 6 h after trauma, blood-brain barrier permeability was equally increased in all mice. However, by 24 h specific gravity measurements of brain edema were significantly worse in WT mice than in KO mice. At 1 and 2 days post-trauma, mice showed deficits in rotarod performance, but by day 7 all mice recovered motor function and there were no differences between WT and KO mice. At 7 days, cortical lesion volumes were significantly reduced in KO mice compared with WT mice. However, there were no significant differences in CA3 hippocampal neuron survival. These data suggest that tPA amplifies cortical brain damage and edema in this mouse model of traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742249     DOI: 10.1097/00001756-200112210-00051

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

1.  Variation in the BDNF gene interacts with age to predict mortality in a prospective, longitudinal cohort with severe TBI.

Authors:  Michelle D Failla; Raj G Kumar; Andrew B Peitzman; Yvette P Conley; Robert E Ferrell; Amy K Wagner
Journal:  Neurorehabil Neural Repair       Date:  2014-07-24       Impact factor: 3.919

2.  Tissue plasminogen activator mediates deleterious complement cascade activation in stroke.

Authors:  Xue-Jun Zhao; Timothy M Larkin; Molly A Lauver; Saif Ahmad; Andrew F Ducruet
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 3.  Coagulopathy in traumatic brain injury.

Authors:  Sherman C Stein; Douglas H Smith
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

4.  The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans.

Authors:  Maithili Sashindranath; Eunice Sales; Maria Daglas; Roxann Freeman; Andre L Samson; Elisa J Cops; Simone Beckham; Adam Galle; Catriona McLean; Cristina Morganti-Kossmann; Jeffrey V Rosenfeld; Rime Madani; Jean-Dominique Vassalli; Enming J Su; Daniel A Lawrence; Robert L Medcalf
Journal:  Brain       Date:  2012-07-20       Impact factor: 13.501

5.  Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Authors:  Junwei Yang; Ryan W Shultz; Wendy M Mars; Rodney E Wegner; Yingjian Li; Chunsun Dai; Kari Nejak; Youhua Liu
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 6.  Desmoteplase: discovery, insights and opportunities for ischaemic stroke.

Authors:  Robert L Medcalf
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

7.  Molecular contributions to neurovascular unit dysfunctions after brain injuries: lessons for target-specific drug development.

Authors:  Amandine Jullienne; Jérôme Badaut
Journal:  Future Neurol       Date:  2013-11-01

Review 8.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

Review 9.  tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.

Authors:  Linda Fredriksson; Daniel A Lawrence; Robert L Medcalf
Journal:  Semin Thromb Hemost       Date:  2016-09-27       Impact factor: 4.180

10.  Blood-brain barrier permeability and tPA-mediated neurotoxicity.

Authors:  Rami Abu Fanne; Taher Nassar; Sergei Yarovoi; Anwar Rayan; Itschak Lamensdorf; Michael Karakoveski; Polianski Vadim; Mahmud Jammal; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Neuropharmacology       Date:  2010-01-06       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.